Neurocrine Biosciences NBIXNasdaq
164.92USDClose on 08/10
At a glance
Neurocrine Biosciences sits in the ‘Resting’ stage of its cycle. It has moved +653.4% since its first surge signal on 2014-12-10, when the past-year gain stood at +129.0%.
- Since surge signal
- +653.4%
- First surge signal
- 2014-12-10
- Price at signal
- 21.89
- Past-year gain (at signal)
- +129.0%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.